The amount of IL-22 required to overcome beta cell ER stress to limit self-antigen presentation and beta cell loss in autoimmune diabetes may differ substantially from that required to contend with the low-level chronic inflammation in obesity and type 2 diabetes. This evidence concerns the gene IL22 and Obesity.